Accueil   Diary - News   All news SUBLIMED obtains the CE mark

SUBLIMED obtains the CE mark

This major step allows SUBLIMED to commercialize in France, as of now, its medical device actiTENS for the management of chronic pain patients.


SUBLIMED, a company specializing in the development of non-drug solutions for the management of chronic pain patients, announces that it has been awarded the CE Mark for its IIa class medical device actiTENS and its smartphone application, which allows it to be piloted and collected patient monitoring datas.




Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree